BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

3 hedge funds and large institutions have $50.2K invested in ProShares UltraShort NASDAQ Biotechnology in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$46.4K

Top Sellers

1
-$1.49M
2
-$652K
3
-$590K
4
TRCT
Tower Research Capital (TRC)
New York
-$205K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$46.4K
2
$2.1K
3
$1.67K
4
–
5
–
6
–
7
–